Endologix Inc. (ELGX) Has Dropped To A New Low For The Year

Endologix Inc. (ELGX) gapped open sharply lower Thursday morning and has continued to fall in early trade. The stock is now down 2.35 at $4.38 on above average volume. Endologix has dropped below support and has set a new low for the year.

Endologix announced Wednesday that, after a meeting with the FDA, it will conduct a confirmatory clinical study of its Nellix EVAS System. The company now estimates that PMA approval will occur in 2020.

For comments and feedback contact: editorial@rttnews.com

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT